Oct 30 (Reuters) - Pharmaxis Ltd (PXS) :
- FDA APPROVES PHARMAXIS, CHIESI'S BRONCHITOL AS THERAPY TO IMPROVE PULMONARY FUNCTION IN ADULT PATIENTS 18 YEARS OF AGE & OLDER WITH CYSTIC FIBROSIS
Source text : (https://bit.ly/37XNE6m)
(([email protected];))
News: PXS FDA Approves Pharmaxis, Chiesi's Bronchitol As Therapy To Improve Pulmonary Function In...
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.10M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.6¢ | 1.5¢ | $6.213K | 390.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 5012750 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 932112 | 6 |
View Market Depth
| Last trade - 15.55pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.6¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 1.5¢ | 1.6¢ | 1.5¢ | 41480 | ||
| Last updated 12.25pm 07/05/2024 ? | |||||
| SNT (ASX) Chart |